These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32239775)

  • 1. Orofacial Strength and Voice Quality as Outcome of Levodopa Challenge Test in Parkinson Disease.
    Lechien JR; Delsaut B; Abderrakib A; Huet K; Delvaux V; Piccaluga M; Khalife M; Harmegnies B; Saussez S; Blecic S
    Laryngoscope; 2020 Dec; 130(12):E896-E903. PubMed ID: 32239775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voice Quality and Orofacial Strength as Outcome of Levodopa Effectiveness in Patients with Early Idiopathic Parkinson Disease: A Preliminary Report.
    Lechien JR; Blecic S; Ghosez Y; Huet K; Harmegnies B; Saussez S
    J Voice; 2019 Sep; 33(5):716-720. PubMed ID: 29724466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voice abnormalities and their relation with motor dysfunction in Parkinson's disease.
    Midi I; Dogan M; Koseoglu M; Can G; Sehitoglu MA; Gunal DI
    Acta Neurol Scand; 2008 Jan; 117(1):26-34. PubMed ID: 18031561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of levodopa on laryngeal muscle activity for voice onset and offset in Parkinson disease.
    Gallena S; Smith PJ; Zeffiro T; Ludlow CL
    J Speech Lang Hear Res; 2001 Dec; 44(6):1284-99. PubMed ID: 11776365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voice Quality Outcomes After Transoral CO
    Lechien JR; Crevier-Buchman L; Circiu MP; De Mones E; de Pemille GV; Julien-Laferriere A; Saussez S; Baudouin R; Remacle M; Hans S
    Otolaryngol Head Neck Surg; 2023 Mar; 168(3):422-428. PubMed ID: 35998041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of levodopa on vocal function in Parkinson's disease.
    Sanabria J; Ruiz PG; Gutierrez R; Marquez F; Escobar P; Gentil M; Cenjor C
    Clin Neuropharmacol; 2001; 24(2):99-102. PubMed ID: 11307045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Laryngopharyngeal Reflux on Subjective, Aerodynamic, and Acoustic Voice Assessments of Responder and Nonresponder Patients.
    Lechien JR; Finck C; Huet K; Khalife M; Fourneau AF; Delvaux V; Piccaluga M; Harmegnies B; Saussez S
    J Voice; 2019 Nov; 33(6):929-939. PubMed ID: 30057272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of levodopa treatment in the voice pattern of Parkinson's disease patients: a systematic review and meta-analysis.
    Pinho P; Monteiro L; Soares MFP; Tourinho L; Melo A; Nóbrega AC
    Codas; 2018 Oct; 30(5):e20170200. PubMed ID: 30304100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship Between Voice and Motor Disabilities of Parkinson's Disease.
    Majdinasab F; Karkheiran S; Soltani M; Moradi N; Shahidi G
    J Voice; 2016 Nov; 30(6):768.e17-768.e22. PubMed ID: 26725551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glottographic measures before and after levodopa treatment in Parkinson's disease.
    Jiang J; Lin E; Wang J; Hanson DG
    Laryngoscope; 1999 Aug; 109(8):1287-94. PubMed ID: 10443835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prosody and levodopa in Parkinson's disease.
    Azevedo LL; Reis CA; Souza IS; Cardoso FE
    Arq Neuropsiquiatr; 2013 Nov; 71(11):835-40. PubMed ID: 24394867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of laryngopharyngeal reflux on subjective and objective voice assessments: a prospective study.
    Lechien JR; Huet K; Khalife M; Fourneau AF; Delvaux V; Piccaluga M; Harmegnies B; Saussez S
    J Otolaryngol Head Neck Surg; 2016 Nov; 45(1):59. PubMed ID: 27825368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voice Quality as Therapeutic Outcome in Laryngopharyngeal Reflux Disease: A Prospective Cohort Study.
    Lechien JR; Finck C; Huet K; Fourneau AF; Khalife M; Delvaux V; Piccaluga M; Harmegnies B; Saussez S
    J Voice; 2020 Jan; 34(1):112-120. PubMed ID: 30220528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Speech and voice disorders in Parkinson's disease].
    Martnez-Sánchez F
    Rev Neurol; 2010 Nov; 51(9):542-50. PubMed ID: 20979034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of Parkinson's-related dysphonia.
    Sewall GK; Jiang J; Ford CN
    Laryngoscope; 2006 Oct; 116(10):1740-4. PubMed ID: 17003722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are the Acoustic Measurements Reliable in the Assessment of Voice Quality? A Methodological Prospective Study.
    Lechien JR; Huet K; Finck C; Blecic S; Delvaux V; Piccaluga M; Saussez S; Harmegnies B
    J Voice; 2021 Mar; 35(2):203-215. PubMed ID: 31558334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Articulation disorders and duration, severity and L-dopa dosage in idiopathic Parkinson's disease.
    Pawlukowska W; Gołąb-Janowska M; Safranow K; Rotter I; Amernik K; Honczarenko K; Nowacki P
    Neurol Neurochir Pol; 2015; 49(5):302-6. PubMed ID: 26377981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voice quality severity and responsiveness to levodopa in Parkinson's disease.
    Cushnie-Sparrow D; Adams S; Abeyesekera A; Pieterman M; Gilmore G; Jog M
    J Commun Disord; 2018; 76():1-10. PubMed ID: 30053648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vocal Characteristics of Elderly Women Engaged in Aerobics in Private Institutions of Salvador, Bahia.
    Colman Machado de Machado F; Cielo CA; Lessa MM; Barbosa LH
    J Voice; 2016 Jan; 30(1):127.e9-19. PubMed ID: 25795360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease.
    Goberman AM
    Med Sci Monit; 2005 Mar; 11(3):CR109-16. PubMed ID: 15735562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.